Hemolytic crisis in a G6PD-deficient infant after ingestion of pumpkin

Gian Vincenzo Zuccotti, Francesca Redaelli, Valentina Gualdi

  • 1Department of Pediatrics, Luigi Sacco Hospital, University of Milan, Via G,B, Grassi, 74, 20157 Milan, Italy. valentina.fabiano@unimi.it.

Insights

A baby with Glucose-6-Phosphate Dehydrogenase deficiency experienced severe jaundice and anemia. This was caused by cross-contaminated food, marking the first reported case of hemolysis from indirectly ingested fava beans.

Area of Science:

  • Pediatrics
  • Toxicology
  • Genetics

Background:

  • Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is a common genetic disorder.
  • Hemolytic anemia can be triggered by certain foods, infections, or drugs in individuals with G6PD deficiency.
  • Fava beans are a well-known trigger for hemolysis in G6PD deficient individuals.

Observation:

  • An 8-month-old infant with diagnosed G6PD deficiency presented with acute severe jaundice and anemia.
  • The infant had no history of drug use or direct fava bean consumption.
  • Fava bean DNA was detected on pumpkin consumed by the infant prior to symptom onset.

Findings:

  • This case represents the first documented instance of hemolysis triggered by the ingestion of food cross-contaminated with fava beans.
  • The presence of fava bean DNA on the pumpkin confirmed the source of the trigger.
  • The infant required blood transfusion due to the severity of the anemia.

Implications:

  • Highlights the risk of cross-contamination in food preparation for vulnerable populations.
  • Emphasizes the need for heightened awareness regarding potential hidden sources of G6PD triggers.
  • Suggests improved food safety protocols to prevent accidental ingestion of allergens or toxins.

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
219
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
206
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
353
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
261